Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Financial Statements and ExhibitsItem 9.01
(d)Exhibits
| Exhibit Number | Description |
| 1.1 | Underwriting Agreement, dated August 17, 2018, by and among Amyris, Inc., B. Riley FBR, Inc., Foris Ventures, LLC, Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. |
AMYRIS, INC. ExhibitEX-1.1 2 exh_11.htm EXHIBIT 1.1 EXHIBIT 1.1 EXECUTION COPY AMYRIS,…To view the full exhibit click here
About Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.